Am­gen goes back to Rhode Is­land to build its first next-gen man­u­fac­tur­ing site in the US

In a bid to lead the way in de­vel­op­ing a new gen­er­a­tion of more ef­fi­cient bi­o­log­ics man­u­fac­tur­ing fa­cil­i­ties, Am­gen $AMGN is in­vest­ing $160 mil­lion in a new plant to be con­struct­ed on its Rhode Is­land base.

The phar­ma gi­ant $AMGN — head­quar­tered in Thou­sand Oaks, CA — has had a long his­to­ry with the 75-acre cam­pus in West Green­wich, RI, since in­her­it­ing it in the Im­munex ac­qui­si­tion in 2001. With the new op­er­a­tion, it plans to add around 150 man­u­fac­tur­ing po­si­tions to the 625-strong team. The state gov­ern­ment was hap­py to hear about that job cre­ation, in ad­di­tion to 200 tem­po­rary con­struc­tion and val­i­da­tion jobs, and has promised $9.5 mil­lion in tax cred­its to move things along.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER